Evidence map›Paper›PMID 11027309›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks.

A J Butte, P Tamayo, D Slonim, T R Golub, I S Kohane

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Statistical genomics in rare cancer.Seminars in cancer biology · 2020
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. IonFlow: a galaxy tool for the analysis of ionomics data sets.Metabolomics : Official journal of the Metabolomic Society · 2021
    Article
  18. Article
  19. Observational
  20. Review

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A J ButteChildren's Hospital Informatics Program and Division of Endocrinology, Department of Medicine, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA. atul_butte@harvard.edu
P Tamayo
D Slonim
T R Golub
I S Kohane

Funding

RESEARCH TRAINING-MEDICAL INFORMATICS 90T15LM007092 · NLM · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Nils Gehlenborg · 1992 to 2026
$32.8M
HEALTH INFO IDENTIFI AND DE-INDENTIFICATION TOOLKITR01LM006587 · NLM · CHILDREN'S HOSPITAL BOSTON · PI KOHANE, ISAAC S. · 1998 to 2000
$311k
NLM NIH HHS 5T15 LM07092-07NLM NIH HHS R01 LM06587-01NLM NIH HHS T15 LM007092
6 · The paper itself

Abstract

In an effort to find gene regulatory networks and clusters of genes that affect cancer susceptibility to anticancer agents, we joined a database with baseline expression levels of 7,245 genes measured by using microarrays in 60 cancer cell lines, to a database with the amounts of 5,084 anticancer agents needed to inhibit growth of those same cell lines. Comprehensive pair-wise correlations were calculated between gene expression and measures of agent susceptibility. Associations weaker than a threshold strength were removed, leaving networks of highly correlated genes and agents called relevance networks. Hypotheses for potential single-gene determinants of anticancer agent susceptibility were constructed. The effect of random chance in the large number of calculations performed was empirically determined by repeated random permutation testing; only associations stronger than those seen in multiply permuted data were used in clustering. We discuss the advantages of this methodology over alternative approaches, such as phylogenetic-type tree clustering and self-organizing maps.

Indexed as

Drug Screening Assays, AntitumorAntineoplastic AgentsGene Expression ProfilingHumansMultigene FamilyRNA, NeoplasmTumor Cells, CulturedAntineoplastic AgentsRNA, Neoplasm

Identifiers

PMID11027309
PMCPMC17315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.